Cargando…
Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease
The regenerative capacity of an adult cardiac tissue is insufficient to repair the massive loss of heart tissue, particularly cardiomyocytes (CMs), following ischemia or other catastrophic myocardial injuries. The delivery methods of therapeutics agents, such as small molecules, growth factors, exos...
Autores principales: | Fan, Chengming, Joshi, Jyotsna, Li, Fan, Xu, Bing, Khan, Mahmood, Yang, Jinfu, Zhu, Wuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326780/ https://www.ncbi.nlm.nih.gov/pubmed/32671049 http://dx.doi.org/10.3389/fbioe.2020.00687 |
Ejemplares similares
-
Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine
por: Joshi, Jyotsna, et al.
Publicado: (2020) -
Microneedle-Mediated Transdermal Delivery of Drug-Carrying Nanoparticles
por: Jiang, Xue, et al.
Publicado: (2022) -
Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment
por: Wang, Huailan, et al.
Publicado: (2021) -
Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair
por: Fan, Chengming, et al.
Publicado: (2020) -
Microneedle-mediated drug delivery for cutaneous diseases
por: Chen, Jian, et al.
Publicado: (2022)